Indian drug major Sun Pharma has entered into a manufacturing and marketing tie-up with US pharma firm Merck’s Indian arm MSD Pharma to develop, manufacture and market generic drugs in emerging markets. The markets on their radar include Asia Pacific, Latin America, Eastern Europe, Middle East and Africa.